This review highlights early but exploratory application of ML for patients' or symptoms classification and predicting clinical outcomes and adverse events following DBS using preoperative clinical data. However, the current evidence is sparse, single-center, and methodologically heterogeneous, with limited external validation. Therefore, clinical translation remains premature.
Javadnia et al. (Wed,) studied this question.